Aidoc vs PathAI

Side-by-side comparison of Aidoc and PathAI: pricing, features, API access, and community ratings.

AI comparison summary

Aidoc focuses on radiology/medical imaging with real-time triage across emergency conditions, serving a broader clinical audience at 1,600+ medical centers with proven workflow integration and time-critical outcomes. PathAI specializes in pathology with deep expertise in tissue analysis, targeting technical users and offering both diagnostic support and drug development/biomarker discovery capabilities through their proprietary network of 450+ pathologists. The core difference is imaging modality (radiology vs. pathology) and use case breadth—Aidoc emphasizes cross-departmental care coordination for acute cases, while PathAI bridges clinical diagnostics with pharmaceutical research.

Aidoc
Aidoc

Clinical AI solutions that turn medical imaging data into actionable insights for better patient outcomes

Visit
PathAI
PathAI

AI-powered pathology platform to improve patient outcomes through precision diagnostics

Visit
Category
Healthcare & biotech
Healthcare & biotech
Pricing
Enterprise
Enterprise
Starting price
Free tier
Audience
All audiences
Technical
API available
Open source
Self-hostable
Model provider
Aidoc (proprietary CARE™ Foundation Models)
PathAI (proprietary)
Founded
2016
2016
Headquarters
Tel Aviv, Israel
Boston, USA
Key strengths
  • ·Largest portfolio of FDA-cleared algorithms on a single platform
  • ·Covers 75% of patients in a health system
  • ·Trusted by 1,600+ medical centers worldwide
  • ·Seamless end-to-end integration into existing IT infrastructure
  • ·AI-powered pathology algorithms
  • ·Large proprietary pathologist contributor network (450+ board-certified pathologists)
  • ·Extensive annotation dataset (32.5M+ annotations)
  • ·FDA-cleared digital pathology platform (AISight® Dx)